Sinsin Pharmaceutical Co. Ltd (002800) — Capital Reinvestment Ratio
Sinsin Pharmaceutical Co. Ltd (002800) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.70 Billion) in capital expenditures (₩871.54 Million). See free cash flow generation of Sinsin Pharmaceutical Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sinsin Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks Sinsin Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for Sinsin Pharmaceutical Co. Ltd from 2015 to 2024. For live market cap and broader valuation context, see Sinsin Pharmaceutical Co. Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩5.94 Billion | ₩1.51 Billion | ▼ -80.1% |
| 2023 | 1.28x | ₩3.93 Billion | ₩5.03 Billion | ▲ +670.0% |
| 2022 | 0.17x | ₩5.46 Billion | ₩907.13 Million | ▼ -99.9% |
| 2021 | 115.70x | ₩23.18 Million | ₩2.68 Billion | ▲ +1702.9% |
| 2020 | 6.42x | ₩1.87 Billion | ₩11.97 Billion | ▼ -80.5% |
| 2018 | 32.86x | ₩774.24 Million | ₩25.44 Billion | ▲ +4103.1% |
| 2017 | 0.78x | ₩4.57 Billion | ₩3.57 Billion | ▼ -70.6% |
| 2016 | 2.66x | ₩2.79 Billion | ₩7.43 Billion | ▲ +166.7% |
| 2015 | 1.00x | ₩5.24 Billion | ₩5.22 Billion | — |